Health authorities in England are launching a targeted vaccination campaign against meningitis B, with approximately a million young people eligible to receive the free jab. The initiative was prompted by an outbreak in Kent earlier this year that resulted in 29 confirmed or suspected cases and two deaths, described as unprecedented and explosive in nature. Nearly 90,000 doses have already been administered, with an additional 135,000 doses scheduled for coming weeks.
The vaccination program targets 17 and 18-year-olds in sixth form, as well as students under 25 who are enrolling in residential colleges or universities for the first time this autumn. Eligible groups include those born between 1 September 2007 and 31 August 2008, plus first-time university and residential college students born on or after 21 July 2001. International students and those from other UK nations studying in England are also included. The vaccine consists of two doses administered at least 28 days apart, with both doses recommended for optimal protection.
Bookings can be arranged through participating pharmacies across England, and eligible individuals can walk in without prior appointment or GP registration if they meet the age and enrollment criteria. The meningitis B vaccine works against a particularly dangerous strain of the disease and does not contain live bacteria. Common side effects include mild injection site reactions and temporary symptoms such as low-grade fever or headache, though serious adverse effects are uncommon.
Meningitis B infection carries significant health risks, potentially causing life-threatening complications including brain inflammation and blood poisoning, as well as long-term disabilities such as hearing loss and amputations. First-year university students face approximately seven times higher risk of infection compared to young people of similar age not attending university, primarily due to increased social mixing and shared living arrangements. The infection spreads through close contact such as kissing, sharing drinks, or living in proximity to infected individuals.
The MenB vaccine was integrated into routine childhood immunizations for babies born on or after 1 July 2015, meaning teenagers and young adults over 11 years old have not previously received the jab. UK vaccine experts are recommending that government officials consider routinely offering the vaccine to all teenagers around age 15. All UK nations are participating in the campaign with slightly different eligibility and enrollment procedures.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI